Snehal Naik

Snehal Naik has a strong background in clinical development and medical affairs. They currently hold the position of Vice President of Clinical Development at Ventyx Biosciences since April 2021. Prior to this role, Naik worked at Arena Pharmaceuticals, Inc. as a Senior Director in Clinical Development from October 2017 to September 2018, and then as a Senior Director in Clinical Development & Medical Affairs from September 2018 to April 2021. Before joining Arena Pharmaceuticals, Naik worked at Prometheus Laboratories Inc., a Nestlé Health Science Company, as a Director in Clinical Development & Medical Affairs from May 2014 to October 2017. Naik gained valuable experience at Pfizer, where they served as a Medical Director in Inflammation from January 2011 to May 2014, as a Medical Director in Hematology from December 2009 to March 2011, and as a Senior Scientist in Global Medical Affairs from July 2007 to December 2009. Naik also worked at Merck as a Senior Manager in Medical Affairs from May 2005 to July 2007. Their earlier experience includes roles as a Postdoctoral Fellow in Cardiovascular Diseases at the University of Pennsylvania School of Medicine from November 2003 to May 2005, and as a Postdoctoral Fellow in Asthma and Inflammation at Thomas Jefferson University from June 2001 to July 2003.

Snehal Naik pursued a Bachelor of Science degree in Biology from the University of Kentucky. Afterwards, Snehal enrolled in the Temple University - Lewis Katz School of Medicine to earn a PhD in Pharmacology. The exact start and end years for these educational experiences are not provided.